Clinical significance of Notch pathway-associated microRNA-107 in pancreatic ductal adenocarcinoma

Papers of special note have been highlighted as: • of interest

References

• 1. CancerNet. Pancreatic cancer: statistics. www.cancer.net/cancer-types/pancreatic-cancer/statistics
  Google Scholar
• 2. Bekkali NLH, Oppong KW. Pancreatic ductal adenocarcinoma epidemiology and risk assessment: could we prevent? Possibility for an early diagnosis. Endosc. Ultrasound 6(Suppl. 3), S58–S61 (2017).
  MedlineGoogle Scholar
• 3. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 74(11), 2913–2921 (2014).
  Medline CASGoogle Scholar
• 4. Bansal P, Sonnenberg A. Pancreatitis is a risk factor for pancreatic cancer. Gastroenterology 109(1), 247–251 (1995).
  Medline CASGoogle Scholar
• 5. American Cancer Society. Pancreatic cancer risk factors. www.cancer.org/cancer/pancreatic-cancer/causes-risks-prevention/risk-factors.html
  Google Scholar
• 6. Talamini G, Bassi C, Falconi M et al. Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer. Dig. Dis. Sci. 44(7), 1303–1311 (1999).
  Medline CASGoogle Scholar
• 7. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2), 281–297 (2004). • Demonstrates the role of epigenetic factor like miRNAs in disease pathogenesis.
  Medline CASGoogle Scholar
• 8. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6(11), 857–866 (2006). • Focuses on the role of miRNAs in human cancers including pancreatic cancer.
  Medline CASGoogle Scholar
• 9. Harbuzariu A, Oprea-Ilies GM, Gonzalez-Perez RR. The role of Notch signaling and leptin–Notch crosstalk in pancreatic cancer. Medicines (Basel) 5(3), 68 (2018). • Reveals the role of developmental Notch pathway in PDAC.
  Medline CASGoogle Scholar
• 10. Gao J, Long B, Wang Z. Role of Notch signaling pathway in pancreatic cancer. Am. J. Cancer Res. 7(2), 173–186 (2017). • Unravels the mechanism of Notch signaling pathway activation in pancreatic cancer.
  Medline CASGoogle Scholar
• 11. Guo H, Lu Y, Wang J et al. Targeting the Notch signaling pathway in cancer therapeutics. Thorac. Cancer 5(6), 473–486 (2014).
  MedlineGoogle Scholar
• 12. Majidinia M, Darband SG, Kaviani M, Nabavi SM, Jahanban-Esfahlan R, Yousefi B. Cross-regulation between Notch signaling pathway and miRNA machinery in cancer. DNA Repair (Amst.) 66–67, 30–41 (2018).
  Medline CASGoogle Scholar
• 13. Carter JT, Grenert JP, Rubenstein L, Stewart L, Way LW. Tumors of the ampulla of vater: histopathologic classification and predictors of survival. J. Am. College Surgeons 207(2), 210–218 (2008).
  MedlineGoogle Scholar
• 14. Warshaw AL, Fernández-del Castillo C. Pancreatic carcinoma. N. Engl. J. Med. 326(7), 455–465 (1992).
  Medline CASGoogle Scholar
• 15. Rhim AD, Stanger BZ. Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways. Prog. Mol. Biol. Transl. Sci. 97, 41–78 (2010).
  Medline CASGoogle Scholar
• 16. Cheng F, Yang Z, Huang F, Yin L, Yan G, Gong G. MicroRNA-107 inhibits gastric cancer cell proliferation and metastasis by targeting PI3K/AKT pathway. Microb. Pathog. 121, 110–114 (2018).
  Medline CASGoogle Scholar
• 17. Sharma P, Saini N, Sharma R. miR-107 functions as a tumor suppressor in human esophageal squamous cell carcinoma and targets Cdc42. Oncol. Rep. 37(5), 3116–3127 (2017).
  Medline CASGoogle Scholar
• 18. Wang P, Liu X, Shao Y et al. MicroRNA-107-5p suppresses non-small cell lung cancer by directly targeting oncogene epidermal growth factor receptor. Oncotarget 8(34), 57012–57023 (2017).
  MedlineGoogle Scholar
• 19. Lu C, Xie Z, Peng Q. miRNA-107 enhances chemosensitivity to paclitaxel by targeting antiapoptotic factor Bcl-w in non small cell lung cancer. Am. J. Cancer Res. 7(9), 1863–1873 (2017).
  Medline CASGoogle Scholar
• 20. Sharma P, Saraya A, Gupta P, Sharma R. Decreased levels of circulating and tissue miR-107 in human esophageal cancer. Biomarkers 18(4), 322–330 (2013).
  Medline CASGoogle Scholar
• 21. Chen L, Zhang R, Li P et al. p53-induced microRNA-107 inhibits proliferation of glioma cells and down-regulates the expression of CDK6 and Notch-2. Neurosci. Lett. 534, 327–332 (2013).
  Medline CASGoogle Scholar
• 22. Li X-Y, Luo Q-F, Wei C-K, Li D-F, Li J, Fang L. miRNA-107 inhibits proliferation and migration by targeting CDK8 in breast cancer. Int. J. Clin. Exp. Med. 7(1), 32–40 (2014).
  MedlineGoogle Scholar
• 23. Molina-Pinelo S, Carnero A, Rivera F et al. miR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer. BMC Cancer 14, 656 (2014).
  MedlineGoogle Scholar
• 24. Chen L, Li Z, Xu S et al. Upregulation of miR-107 inhibits glioma angiogenesis and VEGF expression. Cell. Mol. Neurobiol. 36(1), 113–120 (2016).
  Medline CASGoogle Scholar
• 25. Wang S, Ma G, Zhu H et al. miR-107 regulates tumor progression by targeting NF1 in gastric cancer. Sci. Rep. 6, 36531 (2016).
  Medline CASGoogle Scholar
• 26. Xiong J, Wang D, Wei A et al. Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and PTEN. Exp. Cell Res. 361(2), 316–323 (2017).
  Medline CASGoogle Scholar
• 27. Imamura T, Komatsu S, Ichikawa D et al. Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer. Sci. Rep. 7(1), 5708 (2017).
  MedlineGoogle Scholar
• 28. Mazur PK, Einwächter H, Lee M et al. Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma. Proc. Natl Acad. Sci. USA 107(30), 13438–13443 (2010).
  Medline CASGoogle Scholar
• 29. Saito S, Ishiguro H, Kimura M et al. Clinical significance of NOTCH1 intracellular cytoplasmic domain translocation into the nucleus in gastric cancer. Biomed. Rep. 5(3), 344–348 (2016).
  Medline CASGoogle Scholar
• 30. Catanzaro G, Sabato C, Russo M et al. Loss of miR-107, miR-181c and miR-29a-3p promote activation of Notch2 signaling in pediatric high-grade gliomas (pHGGs). Int. J. Mol. Sci. 18(12), 2742 (2017). • Shows dysregulated expression of miR-107 in gliomas.
  MedlineGoogle Scholar